A methylmercury toxicity model to test for possible adverse effects resulting from chelating agent therapy.

Abstract

A daily dosing model for methylmercury (MM) intoxication was developed for the purpose of testing for possible adverse effects resulting from the administration of complexing agents used in the treatment of MM poisoning. The dithiol complexing agents 2,3-dimercaptopropanol (BAL) and meso-2,3-dimercaptosuccinic acid (DMSA) were chosen to test the discriminative ability of this model, since the former is contraindicated for MM poisoning and causes an increase in target organ MM burden, while the latter compound is known to be efficacious in reducing both toxicity and brain MM content. The basic design of the model called for daily observation of treated animals with identification of the following signs of MM intoxication: loss of body weight, onset of signs of toxicity, and mortality. The degree of toxicity was evaluated, and a toxicity score (0-5) was provided for each animal. A dose-dependent decrease in body weight was found in MM-treated mice. The latent period for development of signs of intoxication varied inversely with the dose rate. The rate of progression of severity of signs of intoxication was also dependent upon the dose. A dose rate of 14 mg Hg per kg per day was utilized to test the effects of BAL and DMSA on the onset and progression of signs of MM intoxication. Onset and progression of signs of methylmercury intoxication were similar for animals receiving methylmercury either alone or with administration of BAL at 2 mg per kg per day. Animals which received BAL at a dose rate of 20 mg per kg per day developed signs of intoxication significantly earlier.(ABSTRACT TRUNCATED AT 250 WORDS)

• Authors: P J Kostyniak, A I Soiefer
• Journal: Journal of applied toxicology : JAT (J Appl Toxicol) Vol. 4 Issue 4 Pg. 206-10 (Aug 1984) ISSN: 0260-437X [Print] England
• PMID: 6092450 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Chelating Agents
• Methylmercury Compounds
• Dimercaprol
• Succimer
• Mercury

Topics

• Animals
• Brain (metabolism)
• Chelating Agents (therapeutic use, toxicity)
• Dimercaprol (therapeutic use, toxicity)
• Disease Models, Animal
• Male
• Mercury (metabolism)
• Methylmercury Compounds (poisoning)
• Mice
• Succimer (therapeutic use, toxicity)
• Time Factors